Core Scientific
Core Scientific carries $2.1B in long-term debt, with $1.1B in scheduled principal maturities. Insufficient data is available to calculate a reliable risk score for CORZ.
Maturity Schedule
| Period | Amount Due |
|---|---|
| Year 1 (0-12 months) | N/A |
| Year 2 (12-24 months) | N/A |
| Year 3 (24-36 months) | N/A |
| Year 4 (36-48 months) | N/A |
| Year 5 (48-60 months) | N/A |
| Beyond 5 Years | $1.1B |
| Total Scheduled Maturities | $1.1B |
Key Metrics
How This Score Was Computed
Only 1 of 5 score components could be calculated — not enough for a reliable composite. The score is withheld rather than published on thin data.
| Component | Value | Sub-Score |
|---|---|---|
|
Near-Term Maturity Concentration
No Year-1 maturity bucket was reported in recent filings.
|
N/A | — |
|
Interest Coverage Ratio
Interest expense was not reported in the latest 10-K.
|
N/A | — |
|
Debt-to-Equity Ratio
Stockholders' equity is negative (-$1.3B); a debt-to-equity ratio is not meaningful against negative equity.
|
N/A | — |
Cash Coverage of Near-Term Debt
Show calculationCash & equivalents / Debt due within 12 months
Cash & equivalents: $1.0B
Near-term debt (balance-sheet DebtCurrent): $994M
No Year-1 maturity bucket was reported, so balance-sheet short-term debt (DebtCurrent) is used as the near-term obligation. This is why cash coverage can be scored even when the maturity schedule shows Year 1 as N/A.
|
1.01x | 5/10 |
|
Cash Runway
Only scored when a company is burning cash. Operating cash flow is positive (or unreported), so runway isn't a constraint.
|
N/A | — |
"Weight Used" shows each component's share after the weights of unscored components are redistributed. Full thresholds and formulas are on the methodology page.
Recent SEC Filings
Material disclosures from Core Scientific's most recent EDGAR filings. 8-K item labels indicate the type of event reported.
| Date | Form | Details |
|---|---|---|
| 2026-05-26 | 8-K | Officer / Director Change, Reg FD Disclosure |
| 2026-05-15 | 8-K | Shareholder Vote |
| 2026-05-06 | 10-Q | Quarterly report |
| 2026-05-06 | 8-K | Earnings Results, Reg FD Disclosure |
| 2026-05-06 | 8-K | Material Agreement, Agreement Terminated, New Debt Obligation, Other Events |
| 2026-05-06 | 8-K | Material Agreement, Reg FD Disclosure |
| 2026-05-05 | 8-K | Officer / Director Change |
| 2026-04-27 | 8-K | Reg FD Disclosure |
Related Companies
Data Source:
Financial data sourced from SEC EDGAR XBRL filings (10-K annual reports).
Fiscal period end: 2026-03-31.
Filing date: 2026-05-06.
Data last fetched: 2026-07-26.
Maturity schedules reflect the company's most recently reported debt repayment obligations.
This company does not tag the standard LongTermDebt concept;
its debt figure comes from DebtLongtermAndShorttermCombinedAmount.
Data quality: Limited.
View SEC EDGAR filings for Core Scientific →